Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited due to allegations of securities law violations, encouraging affected investors to participate in a class action lawsuit [4][6]. Group 1: Allegations Against Pomdoctor - The complaint alleges that Pomdoctor and its executives made false and misleading statements and failed to disclose critical information, including involvement in a fraudulent stock promotion scheme and the use of offshore accounts for share dumping [6]. - Specific allegations include the omission of false rumors and artificial trading activity that inflated the stock price, leading to materially misleading public statements about the company's business and prospects [6]. Group 2: Stock Performance - Pomdoctor's stock experienced a significant decline, dropping from approximately $0.50 per share on December 10, 2025, to about $0.38 per share on December 11, 2025, representing a decline of roughly $0.12 per share or approximately 24% in a single trading session [7]. - This decline was attributed to heightened volatility and selling pressure amid broader investor concerns regarding the company's financial performance and valuation [7]. Group 3: Class Action Details - The deadline for investors to seek the role of lead plaintiff in the federal securities class action against Pomdoctor is April 13, 2026 [4]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will direct and oversee the litigation on behalf of the class [8].
UPCOMING DEADLINE: Pomdoctor Limited (POM) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline